Overview

Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension

Status:
Recruiting
Trial end date:
2021-05-30
Target enrollment:
Participant gender:
Summary
The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery
Phase:
Phase 4
Details
Lead Sponsor:
Zagazig University
Treatments:
Milrinone